S. Boudrias Horticole has been acquired by Fulcrum Capital and BDC Capital
The shareholders of S. Boudrias Horticole Inc. have sold the company to Fulcrum Capital Partners and BDC capital.
S. Boudrias Horticole is a Canadian horticulture distribution company, focused on supplying large retailers, such as The Home Depot and Lowe’s, with private and unique brand names bearing their logo. The company services all of Canada and offers products that range from compost, soil and topsoil, decorative stones, sand and gravel, peat moss and fertilizers to kindling wood.
Fulcrum Capital Partners is an independent private equity firm focused on the Canadian middle market. The firm invests in several industries, including manufacturing, services, distribution and logistics, and consumer products, and creates value by providing strategic, operational, financial and M&A expertise to its investments. BDC Capital is a bank for Canadian entrepreneurs. BDC’s growth equity partners’ team provides minority equity investments to mid-market businesses looking to become leaders in their industry.
Oaklins’ team in Canada acted as advisors to the sellers in this transaction.
Stéphane Boudrias
Founder, S. Boudrias Horticole Inc.
Falar com a equipa da transação
Transações relacionadas
ABZ Seeds has been acquired by Planasa
ABZ Seeds, a renowned breeder of seed-propagated F1 hybrid strawberry varieties, has been acquired by Planasa, a global leader in breeding next-generation berry varieties, including blueberries, blackberries, raspberries and strawberries.
Saber maisDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Saber maisXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Saber mais